ASU's LaBaer Developing Blood-Based Protein Biomarkers for Early Diagnosis of Breast Cancer
December 24, 2010
ASU's LaBaer Developing Blood-Based Protein Biomarkers for Early Diagnosis of Breast Cancer
Consisting of autoantibodies thought to be produced in response to tumor-associated proteins, the biomarker panel is one of the first to have shown potential utility as an early detection tool for breast cancer, LaBaer said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor - NGS-Based Peptide Display Platform Enables Proteome-Wide Screening for Autoantigens
May 27, 2011 / ProteoMonitor - BSI Merges with MBC to Secure Access to Nanoarray Technology and New Academic and Pharma Markets
September 17, 2010 / ProteoMonitor - GMU's Petricoin Building Database That Details Activation in Cancer Protein Pathways
August 13, 2010 / ProteoMonitor - SuppreMol to Use Protagen Biomarker Panel
August 2, 2011 / GenomeWeb Daily News